- In August 2023, Aptos, a leading name in aesthetic medicine, introduced its 4th generation aesthetic threads, incorporating Hyaluronic Acid and utilizing innovative NAMICA technology. This advancement underscores Aptos's dedication to delivering cutting-edge thread technologies that enhance efficacy and longevity in aesthetic procedures. The introduction of these next-generation threads highlights the increasing significance of bio-stimulating ingredients in cosmetic threads, contributing to the development of safer, more effective, and longer-lasting results for patients worldwide
- In August 2023, PDO Max, Inc., a prominent U.S.-based aesthetic medical device firm, launched their latest Molded Levo Max Threads. These threads are specifically designed for efficient contouring of the lower face, jawline, and general submentum area, featuring new bi-directional and barbed threads for enhanced effectiveness. This initiative underscores PDO Max's commitment to driving innovation and improving operational effectiveness within the aesthetic sector, offering practitioners more precise tools for targeted treatments and improved patient outcomes
- In Nov 2023, Aptos LLC continued the broader rollout of its 4th generation aesthetic threads with Hyaluronic Acid, utilizing the innovative NAMICA technology. This ongoing emphasis on advanced technology demonstrates the company’s commitment to integrating cutting-edge solutions into cosmetic thread offerings. This ensures practitioners have access to sophisticated tools that enhance convenience and control, while ensuring robust and natural-looking results in aesthetic procedures across global markets
- In January 2024, MINT PDO threads, manufactured by HansBiomed (South Korea), further solidified their market position by securing additional FDA certifications in the United States. MINT, which stands for Minimally Invasive Nonsurgical Thread, is produced at HansBiomed's state-of-the-art research center. This achievement highlights MINT PDO's commitment to developing cutting-edge safety technologies that provide effective and reliable solutions for practitioners and patients, ensuring greater confidence and peace of mind in cosmetic thread procedures. (Note: While previous FDA clearances were obtained in 2013 and 2020, recent reports indicate ongoing certifications and market expansion efforts)
- In May 2024, Croma-Pharma GmbH (Austria) announced the launch of contoured absorbable PDO threads, which offer an extended shelf life and superior tensile and fixation strength. This development provides a versatile option for medical practitioners and patients seeking effective and durable solutions. This initiative underscores Croma-Pharma's commitment to delivering innovative, reliable aesthetic solutions tailored to the unique needs of the market, reinforcing its position in the rapidly growing global cosmetic threads market
